Correlation Between Procter Gamble and Regeneron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Procter Gamble and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Procter Gamble and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Procter Gamble and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Procter Gamble and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Procter Gamble with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Procter Gamble and Regeneron Pharmaceuticals.
Diversification Opportunities for Procter Gamble and Regeneron Pharmaceuticals
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Procter and Regeneron is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Procter Gamble and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Procter Gamble is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Procter Gamble are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Procter Gamble i.e., Procter Gamble and Regeneron Pharmaceuticals go up and down completely randomly.
Pair Corralation between Procter Gamble and Regeneron Pharmaceuticals
Allowing for the 90-day total investment horizon Procter Gamble is expected to generate 0.66 times more return on investment than Regeneron Pharmaceuticals. However, Procter Gamble is 1.53 times less risky than Regeneron Pharmaceuticals. It trades about -0.05 of its potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest 17,817 in Procter Gamble on November 28, 2024 and sell it today you would lose (684.00) from holding Procter Gamble or give up 3.84% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Procter Gamble vs. Regeneron Pharmaceuticals
Performance |
Timeline |
Procter Gamble |
Regeneron Pharmaceuticals |
Procter Gamble and Regeneron Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Procter Gamble and Regeneron Pharmaceuticals
The main advantage of trading using opposite Procter Gamble and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Procter Gamble position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.Procter Gamble vs. The Clorox | Procter Gamble vs. Colgate Palmolive | Procter Gamble vs. Unilever PLC ADR | Procter Gamble vs. Church Dwight |
Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |